openPR Logo
Press release

Epistaxis Market UpComing Developments With Major Key Players

02-06-2019 12:25 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Epistaxis

Epistaxis

The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025).

Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy. Thus, the rising number of pregnant women suffering from hypertensive diseases is expected to boost the global epistaxis market. Additionally, rising awareness among public regarding the benefits of medical assistance for frequent bouts of bleeding also support the growth of global epistaxis market. Alongside, rise in the geriatric population, as well as rapid technological development in the healthcare sector, add up to the market growth. However, side effects of cauterization procedures such as chemical allergies and pain, swelling, bruises, and running nose may hinder the market growth.

Download the FREE PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/771

Key players are involved in research and development for technological advancements and innovation of epistaxis products. For instance, in 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has a blend of carboxymethylcellulose (CMC) within them exhibiting self-lubricating properties that provide gentle and even compression to the nasal area and helps in the quicker re-conformation of the nasal anatomy. Various similar technological advancements and strategic implementations by emerging and established market players are expected to foster the global epistaxis market growth.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global Epistaxis market based on the following
parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics

The report segments the global epistaxis market on the basis of product type and geography. On the basis of product type, the global epistaxis market is segmented into Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Get FREE Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/771

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epistaxis Market UpComing Developments With Major Key Players here

News-ID: 1564993 • Views:

More Releases from Coherent Market Insights

Potential Growth in the Tissue Plasminogen Activator Market Industry Analysis 2024 Future Scope, Trends with Top Companies by 2031 |F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd
Potential Growth in the Tissue Plasminogen Activator Market Industry Analysis 20 …
Global Tissue Plasminogen Activator Market is estimated to be valued at US$ 2.58 Bn in 2023, and is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030). The Latest study titled Tissue Plasminogen Activator Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics,
Emerging Opportunities in the Endocrine Testing Market Forecast Industry Market Size and Growth Forecast 2024 - 2031 |F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A
Emerging Opportunities in the Endocrine Testing Market Forecast Industry Market …
The Latest study titled Endocrine Testing Product Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the
Eye Health Supplements Market Set To Valuable Growth Rate, Production Overview and Development Technologies by 2031 | |Pfizer Inc, Bausch Health Companies Inc, Alcon, Alliance Pharma PLC
Eye Health Supplements Market Set To Valuable Growth Rate, Production Overview a …
Global Eye Health Supplements Market is estimated to be valued at US$ 2,807.7 Mn in 2023 and is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030). The Latest study titled Eye Health Supplements Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market
Major Player in the Drug For Abuse Testing Devices Market Size Potential Growth 2024 -2031, Industry Analysis, Scope, Share |Alere, Inc., Drägerwerk, Thermo Fisher Scientific
Major Player in the Drug For Abuse Testing Devices Market Size Potential Growth …
The Latest study titled Drug For Abuse Testing Devices Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints.

All 5 Releases


More Releases for Epistaxis

Epistaxis Market to Witness an Outstanding Growth by 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Market Research report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1819 Scope The scope of Market
Epistaxis Market Industry Forecast till 2025
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season. Request Sample Copy of this Business Report
Epistaxis Market Projected to Discern Stable Expansion During 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Fact.MR report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Report overview @ https://www.xploremr.com/report/1819/epistaxis-market Scope The scope of Fact.MR’s report is to analyze the
07-26-2018 | Health & Medicine
Fact.MR
Epistaxis Market Report: Global Epistaxis Market Report Examines Latest Trends a …
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This FactMR report analyzes the expansion of global Epistaxis Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. The scope of FactMR’s report is to analyze the global epistaxis market
Epistaxis Market - Share, Growth, Trends and Forecast 2017 - 2025
Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as anterior epistaxis and posterior epistaxis based on the site where the bleeding originates. Epistaxis is rarely life threatening unless it is associated with chronic disorders such as cancer. About 10% of nosebleeds is life threatening, and it is accounted that four of the 2.4 million deaths occur due
Growing Incidence Rates of Epistaxis and Chronic Diseases Boost the Growth of th …
Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as anterior epistaxis and posterior epistaxis based on the site where the bleeding originates. Epistaxis is rarely life threatening unless it is associated with chronic disorders such as cancer. About 10% of nosebleeds is life threatening, and it is accounted that four of the 2.4 million deaths occur due